Dr Ana Beatris Rossi is a French /Brazilian dermatologist with 27 years of experience practicing dermatology and 17 years’ experience performing clinical studies to evaluate efficacy and safety of drugs, cosmetics & medical devices. She has been working as dermatology expert for several pharmaceutical and cosmetics companies, including Unilever, Johnson & Johnson, Galderma, Novartis and Pierre Fabre. Currently, she is the global head of the Pierre Fabre Clinical & Cosmetovigilance R&D center, and leads a pluri-disciplinary team of 80 scientists that design, perform and coordinate more than 900 clinical studies /year. The activities of this team support the development of products safe and efficacious for the patients-consumers, in the respect of pharmaceutical values and ethics. They also develop new noninvasive or minimally invasive methods of skin and hair evaluation, with several publications in peer reviewed dermatology journals. The cosmetovigilance department is involved in the monitoring of the safety of the product during clinical trials before market access and during commercialisation. The Global Post Marketing Surveillance guarantees the protection of health of cosmetics users by reducing the likelihood of reoccurrence of Undesirable Effects. Dr Rossi is also the head of Cosmetic Dermatology in the University hospital of Toulouse, France, where she teaches residents on aesthetic procedures (chemical peelings, injections, collagen stimulation) and cosmetic science. She is member of the Brazilian, American, European and French Societies of Dermatology and has authored several publications and book chapters in the field of dermatology.